Dashboard
Manage Tickers

CVACCureVac N.V.

Nasdaq curevac.com


$ 3.70 $ -0.28 (-7.05 %)    

Friday, 24-May-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 4.29 (0.95 %)
DIA $ 398.57 $ -0.02 (-0.01 %)
SPY $ 530.36 $ 3.48 (0.66 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 3.69
$ 3.86
$ 0.00 x 0
$ 0.00 x 0
$ 3.68 - $ 4.01
$ 2.22 - $ 12.36
1,783,519
na
826.52M
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

curevacs-cash-and-cash-equivalents-position-of-3002m-as-of-march-31-2024-reaffirming-cash-runway-into-fourth-quarter-of-2025
CureVac's Cash And Cash Equivalents Positi...
05/23/2024 11:13:25

curevac-reported-q1-2024-pre-tax-loss-of-699m-vs-574m-yoy
CureVac Reported Q1 2024 Pre-Tax Loss Of €...
05/23/2024 11:07:31

curevac-q1-2024-sales-12400m-beat-12030m-estimate
CureVac Q1 2024 Sales €12.400M Beat €12.03...
05/23/2024 11:06:14

why-xp-shares-are-trading-lower-by-around-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why XP Shares Are Trading Lower By Around ...
05/22/2024 17:27:59

analog-devices-posts-strong-earnings-joins-tjx-williams-sonoma-and-other-big-stocks-moving-higher-on-wednesday
Analog Devices Posts Strong Earnings, Join...
05/22/2024 14:22:53

despegarcom-posts-strong-sales-joins-reddit-robinhood-and-other-big-stocks-moving-higher-on-friday
Despegar.com Posts Strong Sales, Joins Red...
05/17/2024 14:11:14

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

spirit-airlines-posts-weak-results-joins-integra-lifesciences-bowlero-and-other-big-stocks-moving-lower-on-monday
Spirit Airlines Posts Weak Results, Joins ...
05/06/2024 17:05:12

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

leerink-partners-downgrades-curevac-to-market-perform-lowers-price-target-to-4
Leerink Partners Downgrades CureVac to Mar...
04/25/2024 13:12:43

Leerink Partners analyst Mani Foroohar downgrades CureVac (NASDAQ:CVAC) from Outperform to Market Perform and lowers the pri...

Core News & Articles
CureVac Has Started The Phase 1 Part Of A ...
04/24/2024 11:20:32

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

Core News & Articles
CureVac And GSK Will End The Pandemic Prep...
04/24/2024 11:18:42

curevac-is-implementing-in-2024-an-organizational-redesign-to-streamline-structures-and-reduce-operating-costs-the-program-was-initiated-with-a-voluntary-leaver-program-to-reduce-150-position
CureVac Is Implementing In 2024 An Organiz...
04/24/2024 11:17:22

curevacs-cash-and-cash-equivalents-position-of-4025m-as-of-december-31-2023-is-expected-to-provide-cash-runway-into-q4-2025
CureVac's Cash And Cash Equivalents Positi...
04/24/2024 11:16:17

curevac-q4-sales-22600m-miss-33744m-estimate
CureVac Q4 Sales €22.600M Miss €33.744M Es...
04/24/2024 11:15:00

curevac-and-md-anderson-enter-strategic-collaboration-to-develop-novel-cancer-vaccines
CureVac And MD Anderson Enter Strategic Co...
04/16/2024 11:21:25

guggenheim-reiterates-neutral-on-curevac
Guggenheim Reiterates Neutral on CureVac
04/05/2024 13:57:32

Guggenheim analyst Evan Wang reiterates CureVac (NASDAQ:CVAC) with a Neutral.

curevac-gsk-partner-release-data-on-influenza-vaccine-study
CureVac, GSK Partner Release Data On Influ...
04/04/2024 16:18:36

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

Core News & Articles
CureVac Announces Phase 2 Interim Data fro...
04/04/2024 11:07:12

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

curevac-disclosed-ceo-alexander-zehnder-recently-purchased-50000-common-shares-of-curevac-stock
CureVac Disclosed CEO Alexander Zehnder, R...
01/17/2024 14:13:04

-SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION